Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.

Medicine (Baltimore) 2017 Nov;96(47):e8635

Department of Thoracic Oncology.

Although a few investigators have demonstrated the effect of concurrent chemoradiotherapy (CRT) for postoperative recurrent non-small cell lung cancer (NSCLC), the outcome of this treatment remains unclear. The aim of this study was to elucidate the efficacy and tolerability of concurrent CRT with cisplatin (CDDP) and vinorelbine (VNR) in patients with postoperative locoregional recurrent NSCLC. A total of 40 patients who had received concurrent CRT with CDDP and VNR between January 1999 and December 2014 were retrospectively analyzed. Patients were treated with CDDP (80 mg/m on day 1) and VNR (20 mg/m on days 1 and 8) every 4 weeks. Radiotherapy was administered concurrently during cycle 1. The delivered x-ray radiation dose was 60 Gy in all 37 patients who received x-ray radiotherapy; 3 patients received proton beam radiation (66 Gy [RBE] in 1 patient and 60 Gy [RBE] in 2 patients). The objective response rate was 85% (95% confidence interval [CI], 70.9%-92.9%). The median progression-free survival was 20.3 months (95% CI, 12.9 months-not reached). The 2-year survival rate was 78.9% (95% CI, 63.0%-89.1%). The most common grade ≥3 toxicity was neutropenia (18%). No grade ≥3 radiation pneumonitis and no treatment-related deaths were observed.Our study revealed that concurrent CRT with CDDP and VNR was active and safe for patients with postoperative locoregional recurrent NSCLC. Salvage CRT for postoperative locoregional recurrent NSCLC might be a promising treatment for selected patients.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000008635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708934PMC
November 2017
49 Reads

Publication Analysis

Top Keywords

postoperative locoregional
16
recurrent nsclc
12
concurrent crt
12
locoregional recurrent
12
patients received
12
crt cddp
8
cddp vnr
8
lung cancer
8
patients
8
patients postoperative
8
crt postoperative
8
grade ≥3
8
non-small cell
8
cell lung
8
postoperative
5
crt
5
proton beam
4
rate 85%
4
85% 95%
4
95% confidence
4

Similar Publications